WeSearch
How the opioid black market actually works, according to a former pill mill owner

How the opioid black market actually works, according to a former pill mill owner

·1 min read · 0 reactions · 0 comments · 53 views
More from Business Insider business Compare coverage Trending Talk Blindspots Daily Sources Live wire
TL;DR · WeSearch summary

Jason Votrobek, a former pill mill owner, shares insights into the opioid black market and his experiences in drug trafficking. He discusses the rise of pain clinics that exploited the demand for prescription opioids and the subsequent legal repercussions faced by companies like Purdue Pharma. The opioid crisis continues to have devastating effects, with over 107,000 overdose deaths reported in 2023, primarily due to opioids like fentanyl.

Key facts
About this source

Business Insider files mainly under business. We currently carry 621 of its stories.

Original article
Business Insider
Read full at Business Insider →

Story provenance

Source · retrieval · rights · ranking — open for full record
inspect →

Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.

Record

Original publisherBusiness Insider
Canonical URLhttps://www.businessinsider.com/how-the-opioid-black-market-works-from-a-former-pill-mill-owner-2026-5
Publication timeSat, 23 May 2026 11:00:01 +0000
Retrieval time2026-05-23T11:42:26.397Z
Last seen2026-05-23T11:42:26.397Z
Headline sourcePublisher (no WeSearch rewrite)
Excerpt sourcepublisher body
Excerpt methodFirst ~120 words (~800 chars) of extracted publisher body, fair-use limited.
SummaryWeSearch · cerebras-chat (WeSearch summarizer)
Summary source textcontentText
Citation coverageSummary is a WeSearch-generated derivative; primary citation is the original publisher URL.
ClusterZen8Rx1VXCwg
Cluster logicGrouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison.
Ranking reasonStory pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking.
Publisher visitYes — open original
Substitutes article?No — link-out required for full text

Rights status (four layers)

Publisher-declared
No publisher-confirmed rights record for this source yet.
Machine-readable
No source-specific machine-readable restriction detected beyond the public feed.
WeSearch interpretation
WeSearch declared handling (basis: Derived from the published RSS/Atom feed). This is WeSearch policy, not a legal grant on the publisher's behalf.
Unknown
Retrieval and training permissions are not asserted unless the publisher confirms them.

WeSearch handling by dimension

Indexing May the item be indexed (stored, ranked, made findable)? Allowed
Snippet May a short excerpt of the publisher's text be shown? Allowed
AI summary May WeSearch generate its own short summary of the article? Limited
Retrieval / RAG May the content be exposed for third-party retrieval-augmented generation? Not asserted
Model training May the content be used to train AI models? Not asserted
Commercial reuse May the content be reused commercially? Not permitted

Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.

Opening excerpt (first ~120 words) tap to expand

Jason Votrobek was convicted in 2014 on drug trafficking and money laundering charges and later sentenced to 15 years in federal prison.Votrobek talks to Business Insider about his early days smuggling cocaine and his role in the prescription opioid trade. Votrobek co-owned and operated Atlanta Medical Group, a Georgia clinic that distributed large volumes of oxycodone and other prescription drugs.He describes how pain clinics capitalized on the demand for prescription opioids. Lawsuits against companies like Purdue Pharma, the maker of OxyContin, led to several changes in the system. Purdue and its owners agreed to pay up to $6 billion in a settlement tied to claims over their role in the opioid epidemic.Although the "pill mill" era peaked in the early 2010s, the consequences persist.

Excerpt limited to ~120 words for fair-use compliance. The full article is at Business Insider.

Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from Business Insider